Advancing Clinical Trials Endeavoring to Improve Odds Against Pancreatic Cancer

Palm Beach, FL – (November 28, 2018) – Positive results from clinical trials are headlining the current market for pancreatic cancer treatments in the active biotech industry. Pancreatic cancer is one of the deadliest cancers in the world, but only $90 million is spent annually on research for cures.  As  the  fourth  leading  cause  of  […]

Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare

Strategic Acquisition Gives Company Ownership of Brand Name Drug and Related Market Authorizations in 22 Countries in Which Metastron™ is Already Registered and Approved for Sale   NEW YORK, November 28, 2018 — Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to announce that it has entered into agreement to acquire the […]

Maxtech Advances Brazilian Vanadium Exploration Plan

Strengthens Brazilian Management Team   Vancouver, British Columbia –November 27, 2018 – Maxtech Ventures Inc. (CSE: MVT) (Frankfurt: M1N) (OTC: MTEHF) (“Maxtech” or the “Company”) announces it is moving forward with its Brazilian vanadium exploration initiatives.   Maxtech has existing vanadium claims in Northern Brazil and has engaged Daniel Geyerhahn Garcia, CEO Goldmen Resources Brazil […]

Moleculin Announces New Data Further Supporting Its Lead Drug for Treating Pancreatic Cancer

WP1732 shown to accumulate beneficially in pancreas   HOUSTON – November 28, 2018 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of the M.D. […]

Booming Cannabis Consumables Space Continues to see Product Innovations

Denver CO – November 28, 2018 – The North American Marijuana Index of leading cannabis stocks continues to hold onto the 250 range that it meteorically climbed into at the start of the year.   Growing acceptance of cannabis is setting the stage for a consumable cannabis boom. Major companies have begun to throw their […]

Political Change and E-commerce Drive Ongoing Growth for Cannabis Industry

Denver CO – November 28, 2018 – Years of steady growth in the cannabis industry are expected to continue.   Cannabis industry forecasts anticipate revenues of $146 billion by 2025. Individual U.S. states are already seeing cannabis sales exceed $1 billion in a year. The departure of Jeff Sessions and expected passage of the Farm […]

Chemistree partners with Humboldt County, California cannabis processor

VANCOUVER, Nov. 27, 2018 /PRNewswire/ – Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to announce that the Company has entered into a strategic collaboration (the “Collaboration”) with a Humboldt County-based cannabis processing company (the “Processor”) located in Arcata, California. Pursuant to the Collaboration, Chemistree will loan […]

Emergence of Advanced Electrocardiographic Technologies Show Major Promise for Electrophysiology (EP) Industry

Palm Beach, FL – (November 27, 2018) – The cardiology market within the biotech industry is being revitalized by advancements of Electrocardiographic technologies. North America dominates the global multi-lead Electrocardiographic machines market due to rising aging population and increase in cardiovascular diseases as well as increasing prevalence of cardiac arrhythmias is the primary driver for […]